Noscapine
Thông số
128-62-1Số CAS
204-899-2Số EC
(3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3H-2-benzofuran-1-oneTên IUPAC
C22H23NO7Công thức hóa học
413.4 g/molKhối lượng phân tử
noscapine; 128-62-1; NARCOTINE; Tusscapine; Methoxyhydrastine; Terbenol; Coscopin; Narcompren; Narcosine; Vadebex; Noscapalin; Longatin; Opianine; (-)-Narcotine; Narcotin; Narcotussin; Nectadon; Nicolane; Noscapin; Lyobex; Nipaxon; Opianin; Opian; Coscotabs; alpha-Narcotine; Key-tusscapine; Noscapinum; O-Methylnarcotoline; (-)-alpha-narcotine; Narcotinum; NSC-5366; NSC 5366; DTXSID4023385; 8V32U4AOQU; NSC5366; DTXCID303385; (3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-2H,5H,6H,7H,8H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-1,3-dihydro-2-benzofuran-1-one; (3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3H-2-benzofuran-1-one; 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)-isoquinolin-5-yl), (S-(R*,S*))-; Tropfen, Capval; (3S)-6,7-dimethoxy-3-((5R)-4-methoxy-6-methyl-2H,5H,6H,7H,8H-(1,3)dioxolo(4,5-g)isoquinolin-5-yl)-1,3-dihydro-2-benzofuran-1-one; (3S)-6,7-dimethoxy-3-((5R)-4-methoxy-6-methyl-7,8-dihydro-5H-(1,3)dioxolo(4,5-g)isoquinolin-5-yl)-3H-2-benzofuran-1-one; noscapin hydrochloride; prikkelhoest, Librochin; Hydrochloride, Noscapine; camphoscapine (camsilate); RefChem:927938; Embonate, Noscapine Hydrogen; Hydrogen Embonate, Noscapine; R05DA07; (3S)-6,7-Dimethoxy-3-((5R)-4-methoxy-6-methyl-5,6,7,8-tetrahydro(1,3)dioxolo(4,5-g)isoquinolin-5-yl)isobenzofuran-1(3H)-one; 204-899-2; Capval; Narkotin; Noscapal; Noscapina; L-alpha-Narcotine; Longactin; Hederix (free base); Noscopine; (-)-.alpha.-Narcotine; .alpha.-Narcotine; dl-Narcotine; (+/-)-Noscapine; L-.alpha.-Narcotine; (S,R)-Noscapine; MFCD00069316; A4C6WE7BZN; (S)-6,7-dimethoxy-3-((R)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)isobenzofuran-1(3H)-one; Noscapine base; alpha-Gnoscopine; (3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-2-benzofuran-1(3H)-one; 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-((5R)-5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (3S)-rel-; 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (R*,S*)-; C22H23NO7; Narcotine alkaloid; Noskapin; .alpha.-Gnoscopine; Noscapine dl-form; L-alpha-Noscapine; 8-Methoxyhydrastin; Coscopin (VAN); (3S)-6,7-Dimethoxy-3-[(5R)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-2H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-2-benzofuran-1(3H)-one; (3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3H-isobenzofuran-1-one; SMR000059119; (+-)-Noscapine; (-)-.alpha.-Norcotine; (-)-alpha-Norcotine; (+-)-alpha-Narcotine; 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-, [S-(R*,S*)]-; Noscapinum [INN-Latin]; Noscapina [INN-Spanish]; UNII-A4C6WE7BZN; UNII-8V32U4AOQU; CCRIS 9304; NSC-96350; Noscapine CRS; HSDB 3372; Noscapine [USP:INN:BAN:JAN]; .beta.-Narcotine; (-)-noscapine; NCGC00016388-01; [S-(R*,S*)]-6,7-Dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-1(3H)-Isobenzofuranone; 08N; 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (S-(R*,S*))-; CAS-128-62-1; Prestwick_959; (-)-a-Narcotine; EINECS 204-899-2; NSC 96350; Noscapine (narcotine); 1-.alpha.-Narcotine; BRN 0099933; Tocris-1697; Narcotine, (+-)-; NOSCAPINE [INN]; NOSCAPINE [JAN]; NOSCAPINE [MI]; NOSCAPINE [HSDB]; Prestwick0_000563; Prestwick1_000563; Prestwick2_000563; Prestwick3_000563; NARCOTINUM [HPUS]; Papaverine EP Impurity A; CBMicro_048259; NOSCAPINE [MART.]; NOSCAPINE [USP-RS]; NOSCAPINE [WHO-DD]; NOSCAPINE [WHO-IP]; SCHEMBL4559; (S,R)-Noscapine, 97%; Lopac0_000840; BSPBio_000346; 4-27-00-06838 (Beilstein Handbook Reference); MLS000069475; MLS001060855; SPBio_002565; Noscapine (JP15/USP/INN); Noscapine (JP18/USP/INN); BPBio1_000382; CHEMBL364713; NOSCAPINE DL-FORM [MI]; NOSCAPINE [EP MONOGRAPH]; NOSCAPINE, (+/-)-; SCHEMBL29365828; CHEBI:73237; GTPL10212; NOSCAPINE [USP MONOGRAPH]; NOSCAPINUM [WHO-IP LATIN]; DTXSID901032089; GLXC-22722; HMS1569B08; HMS2096B08; HMS2269P05; 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-((5R)-5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (3S)-; 6,7-Dimethoxy-3-(4-methoxy-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-2-benzofuran-1(3H)-one, (S-(R*,S*))- #; MSK10431; Phthalide, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-; (+/-)-.ALPHA.-NARCOTINE; Tox21_110413; BBL012344; BDBM50424716; NSC121869; STK054401; Noscapine 1.0 mg/ml in Acetonitrile; AKOS000278036; Tox21_110413_1; CCG-204096; CS-5115; DB06174; FN09246; NSC-121869; SDCCGSBI-0048054.P004; (-)-3-(2-Methyl-6,7-methylendioxy-8-methoxy-1-isochinolyl)-6,7-dimethoxyphthalid; NCGC00023230-02; NCGC00023230-04; NCGC00023230-05; NCGC00023230-07; NCGC00023230-08; NCGC00023230-10; NCGC00023230-13; NCGC00023230-14; NCGC00023230-28; 5-(6,7-Dimethoxyphthalidyl)-5,6,7,8-tetrahydro-4-methoxy-8-methyl-1,3-dioxolo(4,5-g)isoquinoline; AC-20272; AC-33191; HY-13716; L-alpha-2-Methyl-8-methoxy-6,7-methylenedioxy-1-(6,7-dimethoxy-3-phthalidyl)-1,2,3,4-tetrahydroisoquinaline; NCI60_004322; VS-03291; BIM-0048054.P001; NS00117949; C09592; D01036; EN300-24402818; SR-01000075529-6; BRD-K89237706-001-03-8; Q60998699; Noscapine, European Pharmacopoeia (EP) Reference Standard; Noscapine, United States Pharmacopeia (USP) Reference Standard; WLN: T C566 DO FO KN EH & & TJ HO1 K1 J-DT56 BVO DHJ HO1 IO1; (3S)-3-[(5R)-6-methyl-4-(methyloxy)-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-6,7-bis(methyloxy)-2-benzofuran-1(3H)-one; (3S)-6,7-Dimethoxy-3-[(5R)-5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo [4, 5-g]isoquinolin-5-yl] phthalide; (S,R)-Noscapine; (S)-6,7-dimethoxy-3-((R)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)isobenzofuran-1(3H)-one; 1(3H)-Isobenzofuranone, 6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (R*,S*)-(+-)-; 1(3H)-Isobenzofuranone,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-, [S-(R*,S*)]-; Phthalide,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-Tên gọi khác
Sản phẩm chứa Noscapine
에치탑에스캡슐일양용비산쿨산콜콜트로키요를레이트로키마파람과립바스크롱에프캡슐네오콜코프캡슐엑스콜코프캡슐미놀에프트로키(페퍼민트맛, 오렌지맛, 모과맛, 복숭아맛)하드코프캡슐노스핀캡슐속콜큐어캡슐
Trang 1/3
Công ty đang bán Noscapine
(주
(주)한풍제약Republic of Korea(주
(주)보령Republic of Korea일양
일양약품(주)Republic of Korea오스
오스틴제약(주)Republic of Korea경주
경남제약 주식회사 아산공장Republic of KoreaAC
Alkaloida Chemical Company ZrtHungaryDP
Darou Pakhsh Pharma ChemIranHA
Hasti Aria ShimiIranTrang 1/3